01
Isolated tests
Results returned without integrated care, follow-up or accountability.
Precision Medicine Ecosystem
Building the Future of Precision Medicine
Transforming medical innovation into clinically governed Medical Programmes through independent clinical leadership and AI-native operating capabilities.
Why healthcare must change
Precision science is moving faster than the systems that deliver it.
Genomics, molecular diagnostics and multi-omic tools are producing insight at pace. Yet most patients still receive care shaped by episodic encounters and one-off tests — not by continuous, personalised programmes.
Care model
Episodic
Encounter-based, reactive.
What patients need
Longitudinal
Continuous, governed, personalised.
Innovation cadence
Accelerating
Assays, models, evidence.
Adoption cadence
Lagging
Governance and workflow gaps.
The adoption gap
A validated innovation is not yet care.
Between a promising result in a study and a benefit reliably delivered to a patient sits the operational reality of healthcare: eligibility, workflow, oversight, follow-up and outcome measurement. Closing that gap is the work.
02
Fragmented innovation
Diagnostics, therapeutics and data assets siloed across organisations.
03
Governance friction
Clinical oversight and operational tooling missing at the point of use.
The ecosystem
From innovation to Medical Programmes, at scale.
Innovators and labs contribute science. GMG applies Healthcare Productisation™ to design clinically governed Medical Programmes. GKIM provides the AI-native technology that enables them to run reliably.
Healthcare Productisation™
A method for turning innovation into repeatable clinical care.
Healthcare Productisation™ is GMG's methodology for wrapping validated science in eligibility criteria, protocols, longitudinal care design and outcome measurement — so the same clinical benefit can be delivered, again and again, with governance intact.
Method
Programme design
Define patient population, eligibility, care pathway, oversight model and measured outcomes.
Method
Governed delivery
Clinical accountability and safety embedded from first pilot through wider implementation.
Method
Continuous evidence
Outcomes captured longitudinally and fed back into programme improvement.
GMG
Clinical leadership and programme delivery.
Genetics Medical Group is an independent clinical organisation. GMG designs, governs and delivers Medical Programmes — retaining full authority over care decisions, safety and patient outcomes.
GKIM
AI-native technology and transformation.
GKIM is an independent technology partner. It provides the platform, knowledge engineering, integration and transformation capabilities that enable Medical Programmes to scale — without ever substituting for clinical judgement.
Evidence
An evidence programme, built openly.
We publish outcomes and case reports only when they are ready. In the meantime, this is what the evidence programme will address.
Evidence in development
Programme outcome studies
Longitudinal outcomes across representative Medical Programmes.
Evidence in development
Adoption and workflow evidence
How governance and AI-native tooling change delivery reliability.
Evidence in development
Health-economic reporting
Cost, utilisation and value evidence for partner organisations.
Partner pathways
Six ways organisations enter the ecosystem.
Partner
Diagnostic labs
Route validated assays into governed Medical Programmes.
Partner
Innovators
Translate research and product into clinical delivery.
Partner
Healthcare providers
Adopt precision programmes with governance intact.
Partner
Employers
Offer clinically governed precision health to workforces.
Partner
Technology partners
Integrate with the GKIM AI-native platform.
Partner
Health systems
System-wide programme design and transformation.
Insights
Editorial from the ecosystem.
Structured perspectives on governance, adoption, AI-native operations and Medical Programme design.
Begin a conversation